Global Opioid-Induced Constipation (OIC) Treatment Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
Opioids are a class of medications that are regularly endorsed for their pain relieving, or pain-killing, properties it is chronic and non-cancer pain. A typical symptom connected with the utilization of these medications are that they decrease the gastrointestinal tract's motility, making solid discharges and making patients strain. In addition, prolonged utilization of opioids can prompt the harm of sensory system that causes body cells to quit creating endogenous opioids, for example, endorphins. There is high risk of constipation in adults since they have poor diet, poor fluid intake and immobility. The typical symptoms for opioid-induced constipation are feeling lethargic, hard and dry stools, distention and bulged abdomen, painful defecation and loss of appetite. The opioid-induced constipation (OIC) treatment market is an exceptionally alluring and promising market because of the expanding base of opioid-induced constipation OIC sufferers.
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Opioid-Induced Constipation (OIC) Treatment market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Opioid-Induced Constipation (OIC) Treatment market are covered in Chapter 9:
Takeda Pharmaceutical Company Limited
Cubist Pharmaceuticals
AIKO Biotechnology
S.L.A. Pharma AG
AstraZeneca plc, Inc.
GlaxoSmithKline, Inc.
Salix Pharmaceuticals, Inc.
Pfizer, Inc.
In Chapter 5 and Chapter 7.3, based on types, the Opioid-Induced Constipation (OIC) Treatment market from 2017 to 2027 is primarily split into:
Peripherally-Restricted ?-opioid Receptor Antagonist (PAMORA)
Non-selective opioid antagonist
?-Opioid antagonist
Locally Acting Chloride Channel Activator (LACCA)
In Chapter 6 and Chapter 7.4, based on applications, the Opioid-Induced Constipation (OIC) Treatment market from 2017 to 2027 covers:
Drug store
Independent Pharmacies
Hospital Pharmacies
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Opioid-Induced Constipation (OIC) Treatment market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Opioid-Induced Constipation (OIC) Treatment Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Opioid-Induced Constipation (OIC) Treatment market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Opioid-Induced Constipation (OIC) Treatment market are covered in Chapter 9:
Takeda Pharmaceutical Company Limited
Cubist Pharmaceuticals
AIKO Biotechnology
S.L.A. Pharma AG
AstraZeneca plc, Inc.
GlaxoSmithKline, Inc.
Salix Pharmaceuticals, Inc.
Pfizer, Inc.
In Chapter 5 and Chapter 7.3, based on types, the Opioid-Induced Constipation (OIC) Treatment market from 2017 to 2027 is primarily split into:
Peripherally-Restricted ?-opioid Receptor Antagonist (PAMORA)
Non-selective opioid antagonist
?-Opioid antagonist
Locally Acting Chloride Channel Activator (LACCA)
In Chapter 6 and Chapter 7.4, based on applications, the Opioid-Induced Constipation (OIC) Treatment market from 2017 to 2027 covers:
Drug store
Independent Pharmacies
Hospital Pharmacies
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Opioid-Induced Constipation (OIC) Treatment market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Opioid-Induced Constipation (OIC) Treatment Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 OPIOID-INDUCED CONSTIPATION (OIC) TREATMENT MARKET OVERVIEW
1.1 Product Overview and Scope of Opioid-Induced Constipation (OIC) Treatment Market
1.2 Opioid-Induced Constipation (OIC) Treatment Market Segment by Type
1.2.1 Global Opioid-Induced Constipation (OIC) Treatment Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Opioid-Induced Constipation (OIC) Treatment Market Segment by Application
1.3.1 Opioid-Induced Constipation (OIC) Treatment Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Opioid-Induced Constipation (OIC) Treatment Market, Region Wise (2017-2027)
1.4.1 Global Opioid-Induced Constipation (OIC) Treatment Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2017-2027)
1.4.3 Europe Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2017-2027)
1.4.4 China Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2017-2027)
1.4.5 Japan Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2017-2027)
1.4.6 India Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2017-2027)
1.4.8 Latin America Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2017-2027)
1.5 Global Market Size of Opioid-Induced Constipation (OIC) Treatment (2017-2027)
1.5.1 Global Opioid-Induced Constipation (OIC) Treatment Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Opioid-Induced Constipation (OIC) Treatment Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Opioid-Induced Constipation (OIC) Treatment Market
2 INDUSTRY OUTLOOK
2.1 Opioid-Induced Constipation (OIC) Treatment Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Opioid-Induced Constipation (OIC) Treatment Market Drivers Analysis
2.4 Opioid-Induced Constipation (OIC) Treatment Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Opioid-Induced Constipation (OIC) Treatment Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Opioid-Induced Constipation (OIC) Treatment Industry Development
3 GLOBAL OPIOID-INDUCED CONSTIPATION (OIC) TREATMENT MARKET LANDSCAPE BY PLAYER
3.1 Global Opioid-Induced Constipation (OIC) Treatment Sales Volume and Share by Player (2017-2022)
3.2 Global Opioid-Induced Constipation (OIC) Treatment Revenue and Market Share by Player (2017-2022)
3.3 Global Opioid-Induced Constipation (OIC) Treatment Average Price by Player (2017-2022)
3.4 Global Opioid-Induced Constipation (OIC) Treatment Gross Margin by Player (2017-2022)
3.5 Opioid-Induced Constipation (OIC) Treatment Market Competitive Situation and Trends
3.5.1 Opioid-Induced Constipation (OIC) Treatment Market Concentration Rate
3.5.2 Opioid-Induced Constipation (OIC) Treatment Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL OPIOID-INDUCED CONSTIPATION (OIC) TREATMENT SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Opioid-Induced Constipation (OIC) Treatment Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Opioid-Induced Constipation (OIC) Treatment Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Opioid-Induced Constipation (OIC) Treatment Market Under COVID-19
4.5 Europe Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Opioid-Induced Constipation (OIC) Treatment Market Under COVID-19
4.6 China Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Opioid-Induced Constipation (OIC) Treatment Market Under COVID-19
4.7 Japan Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Opioid-Induced Constipation (OIC) Treatment Market Under COVID-19
4.8 India Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Opioid-Induced Constipation (OIC) Treatment Market Under COVID-19
4.9 Southeast Asia Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Under COVID-19
4.10 Latin America Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Opioid-Induced Constipation (OIC) Treatment Market Under COVID-19
4.11 Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Market Under COVID-19
5 GLOBAL OPIOID-INDUCED CONSTIPATION (OIC) TREATMENT SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Opioid-Induced Constipation (OIC) Treatment Sales Volume and Market Share by Type (2017-2022)
5.2 Global Opioid-Induced Constipation (OIC) Treatment Revenue and Market Share by Type (2017-2022)
5.3 Global Opioid-Induced Constipation (OIC) Treatment Price by Type (2017-2022)
5.4 Global Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue and Growth Rate of Peripherally-Restricted ?-opioid Receptor Antagonist (PAMORA) (2017-2022)
5.4.2 Global Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue and Growth Rate of Non-selective opioid antagonist (2017-2022)
5.4.3 Global Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue and Growth Rate of ?-Opioid antagonist (2017-2022)
5.4.4 Global Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue and Growth Rate of Locally Acting Chloride Channel Activator (LACCA) (2017-2022)
6 GLOBAL OPIOID-INDUCED CONSTIPATION (OIC) TREATMENT MARKET ANALYSIS BY APPLICATION
6.1 Global Opioid-Induced Constipation (OIC) Treatment Consumption and Market Share by Application (2017-2022)
6.2 Global Opioid-Induced Constipation (OIC) Treatment Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate of Drug store (2017-2022)
6.3.2 Global Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate of Independent Pharmacies (2017-2022)
6.3.3 Global Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate of Hospital Pharmacies (2017-2022)
7 GLOBAL OPIOID-INDUCED CONSTIPATION (OIC) TREATMENT MARKET FORECAST (2022-2027)
7.1 Global Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Opioid-Induced Constipation (OIC) Treatment Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Opioid-Induced Constipation (OIC) Treatment Price and Trend Forecast (2022-2027)
7.2 Global Opioid-Induced Constipation (OIC) Treatment Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Opioid-Induced Constipation (OIC) Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Opioid-Induced Constipation (OIC) Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Opioid-Induced Constipation (OIC) Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Opioid-Induced Constipation (OIC) Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Opioid-Induced Constipation (OIC) Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Opioid-Induced Constipation (OIC) Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Opioid-Induced Constipation (OIC) Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Opioid-Induced Constipation (OIC) Treatment Revenue and Growth Rate of Peripherally-Restricted ?-opioid Receptor Antagonist (PAMORA) (2022-2027)
7.3.2 Global Opioid-Induced Constipation (OIC) Treatment Revenue and Growth Rate of Non-selective opioid antagonist (2022-2027)
7.3.3 Global Opioid-Induced Constipation (OIC) Treatment Revenue and Growth Rate of ?-Opioid antagonist (2022-2027)
7.3.4 Global Opioid-Induced Constipation (OIC) Treatment Revenue and Growth Rate of Locally Acting Chloride Channel Activator (LACCA) (2022-2027)
7.4 Global Opioid-Induced Constipation (OIC) Treatment Consumption Forecast by Application (2022-2027)
7.4.1 Global Opioid-Induced Constipation (OIC) Treatment Consumption Value and Growth Rate of Drug store(2022-2027)
7.4.2 Global Opioid-Induced Constipation (OIC) Treatment Consumption Value and Growth Rate of Independent Pharmacies(2022-2027)
7.4.3 Global Opioid-Induced Constipation (OIC) Treatment Consumption Value and Growth Rate of Hospital Pharmacies(2022-2027)
7.5 Opioid-Induced Constipation (OIC) Treatment Market Forecast Under COVID-19
8 OPIOID-INDUCED CONSTIPATION (OIC) TREATMENT MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Opioid-Induced Constipation (OIC) Treatment Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Opioid-Induced Constipation (OIC) Treatment Analysis
8.6 Major Downstream Buyers of Opioid-Induced Constipation (OIC) Treatment Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Opioid-Induced Constipation (OIC) Treatment Industry
9 PLAYERS PROFILES
9.1 Takeda Pharmaceutical Company Limited
9.1.1 Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification
9.1.3 Takeda Pharmaceutical Company Limited Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Cubist Pharmaceuticals
9.2.1 Cubist Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification
9.2.3 Cubist Pharmaceuticals Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 AIKO Biotechnology
9.3.1 AIKO Biotechnology Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification
9.3.3 AIKO Biotechnology Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 S.L.A. Pharma AG
9.4.1 S.L.A. Pharma AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification
9.4.3 S.L.A. Pharma AG Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 AstraZeneca plc, Inc.
9.5.1 AstraZeneca plc, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification
9.5.3 AstraZeneca plc, Inc. Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 GlaxoSmithKline, Inc.
9.6.1 GlaxoSmithKline, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification
9.6.3 GlaxoSmithKline, Inc. Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Salix Pharmaceuticals, Inc.
9.7.1 Salix Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification
9.7.3 Salix Pharmaceuticals, Inc. Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Pfizer, Inc.
9.8.1 Pfizer, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification
9.8.3 Pfizer, Inc. Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Opioid-Induced Constipation (OIC) Treatment Market
1.2 Opioid-Induced Constipation (OIC) Treatment Market Segment by Type
1.2.1 Global Opioid-Induced Constipation (OIC) Treatment Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Opioid-Induced Constipation (OIC) Treatment Market Segment by Application
1.3.1 Opioid-Induced Constipation (OIC) Treatment Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Opioid-Induced Constipation (OIC) Treatment Market, Region Wise (2017-2027)
1.4.1 Global Opioid-Induced Constipation (OIC) Treatment Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2017-2027)
1.4.3 Europe Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2017-2027)
1.4.4 China Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2017-2027)
1.4.5 Japan Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2017-2027)
1.4.6 India Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2017-2027)
1.4.8 Latin America Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Market Status and Prospect (2017-2027)
1.5 Global Market Size of Opioid-Induced Constipation (OIC) Treatment (2017-2027)
1.5.1 Global Opioid-Induced Constipation (OIC) Treatment Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Opioid-Induced Constipation (OIC) Treatment Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Opioid-Induced Constipation (OIC) Treatment Market
2 INDUSTRY OUTLOOK
2.1 Opioid-Induced Constipation (OIC) Treatment Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Opioid-Induced Constipation (OIC) Treatment Market Drivers Analysis
2.4 Opioid-Induced Constipation (OIC) Treatment Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Opioid-Induced Constipation (OIC) Treatment Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Opioid-Induced Constipation (OIC) Treatment Industry Development
3 GLOBAL OPIOID-INDUCED CONSTIPATION (OIC) TREATMENT MARKET LANDSCAPE BY PLAYER
3.1 Global Opioid-Induced Constipation (OIC) Treatment Sales Volume and Share by Player (2017-2022)
3.2 Global Opioid-Induced Constipation (OIC) Treatment Revenue and Market Share by Player (2017-2022)
3.3 Global Opioid-Induced Constipation (OIC) Treatment Average Price by Player (2017-2022)
3.4 Global Opioid-Induced Constipation (OIC) Treatment Gross Margin by Player (2017-2022)
3.5 Opioid-Induced Constipation (OIC) Treatment Market Competitive Situation and Trends
3.5.1 Opioid-Induced Constipation (OIC) Treatment Market Concentration Rate
3.5.2 Opioid-Induced Constipation (OIC) Treatment Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL OPIOID-INDUCED CONSTIPATION (OIC) TREATMENT SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Opioid-Induced Constipation (OIC) Treatment Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Opioid-Induced Constipation (OIC) Treatment Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Opioid-Induced Constipation (OIC) Treatment Market Under COVID-19
4.5 Europe Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Opioid-Induced Constipation (OIC) Treatment Market Under COVID-19
4.6 China Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Opioid-Induced Constipation (OIC) Treatment Market Under COVID-19
4.7 Japan Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Opioid-Induced Constipation (OIC) Treatment Market Under COVID-19
4.8 India Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Opioid-Induced Constipation (OIC) Treatment Market Under COVID-19
4.9 Southeast Asia Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Under COVID-19
4.10 Latin America Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Opioid-Induced Constipation (OIC) Treatment Market Under COVID-19
4.11 Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Market Under COVID-19
5 GLOBAL OPIOID-INDUCED CONSTIPATION (OIC) TREATMENT SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Opioid-Induced Constipation (OIC) Treatment Sales Volume and Market Share by Type (2017-2022)
5.2 Global Opioid-Induced Constipation (OIC) Treatment Revenue and Market Share by Type (2017-2022)
5.3 Global Opioid-Induced Constipation (OIC) Treatment Price by Type (2017-2022)
5.4 Global Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue and Growth Rate of Peripherally-Restricted ?-opioid Receptor Antagonist (PAMORA) (2017-2022)
5.4.2 Global Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue and Growth Rate of Non-selective opioid antagonist (2017-2022)
5.4.3 Global Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue and Growth Rate of ?-Opioid antagonist (2017-2022)
5.4.4 Global Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue and Growth Rate of Locally Acting Chloride Channel Activator (LACCA) (2017-2022)
6 GLOBAL OPIOID-INDUCED CONSTIPATION (OIC) TREATMENT MARKET ANALYSIS BY APPLICATION
6.1 Global Opioid-Induced Constipation (OIC) Treatment Consumption and Market Share by Application (2017-2022)
6.2 Global Opioid-Induced Constipation (OIC) Treatment Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate of Drug store (2017-2022)
6.3.2 Global Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate of Independent Pharmacies (2017-2022)
6.3.3 Global Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate of Hospital Pharmacies (2017-2022)
7 GLOBAL OPIOID-INDUCED CONSTIPATION (OIC) TREATMENT MARKET FORECAST (2022-2027)
7.1 Global Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Opioid-Induced Constipation (OIC) Treatment Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Opioid-Induced Constipation (OIC) Treatment Price and Trend Forecast (2022-2027)
7.2 Global Opioid-Induced Constipation (OIC) Treatment Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Opioid-Induced Constipation (OIC) Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Opioid-Induced Constipation (OIC) Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Opioid-Induced Constipation (OIC) Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Opioid-Induced Constipation (OIC) Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Opioid-Induced Constipation (OIC) Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Opioid-Induced Constipation (OIC) Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Opioid-Induced Constipation (OIC) Treatment Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Opioid-Induced Constipation (OIC) Treatment Revenue and Growth Rate of Peripherally-Restricted ?-opioid Receptor Antagonist (PAMORA) (2022-2027)
7.3.2 Global Opioid-Induced Constipation (OIC) Treatment Revenue and Growth Rate of Non-selective opioid antagonist (2022-2027)
7.3.3 Global Opioid-Induced Constipation (OIC) Treatment Revenue and Growth Rate of ?-Opioid antagonist (2022-2027)
7.3.4 Global Opioid-Induced Constipation (OIC) Treatment Revenue and Growth Rate of Locally Acting Chloride Channel Activator (LACCA) (2022-2027)
7.4 Global Opioid-Induced Constipation (OIC) Treatment Consumption Forecast by Application (2022-2027)
7.4.1 Global Opioid-Induced Constipation (OIC) Treatment Consumption Value and Growth Rate of Drug store(2022-2027)
7.4.2 Global Opioid-Induced Constipation (OIC) Treatment Consumption Value and Growth Rate of Independent Pharmacies(2022-2027)
7.4.3 Global Opioid-Induced Constipation (OIC) Treatment Consumption Value and Growth Rate of Hospital Pharmacies(2022-2027)
7.5 Opioid-Induced Constipation (OIC) Treatment Market Forecast Under COVID-19
8 OPIOID-INDUCED CONSTIPATION (OIC) TREATMENT MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Opioid-Induced Constipation (OIC) Treatment Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Opioid-Induced Constipation (OIC) Treatment Analysis
8.6 Major Downstream Buyers of Opioid-Induced Constipation (OIC) Treatment Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Opioid-Induced Constipation (OIC) Treatment Industry
9 PLAYERS PROFILES
9.1 Takeda Pharmaceutical Company Limited
9.1.1 Takeda Pharmaceutical Company Limited Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification
9.1.3 Takeda Pharmaceutical Company Limited Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Cubist Pharmaceuticals
9.2.1 Cubist Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification
9.2.3 Cubist Pharmaceuticals Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 AIKO Biotechnology
9.3.1 AIKO Biotechnology Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification
9.3.3 AIKO Biotechnology Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 S.L.A. Pharma AG
9.4.1 S.L.A. Pharma AG Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification
9.4.3 S.L.A. Pharma AG Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 AstraZeneca plc, Inc.
9.5.1 AstraZeneca plc, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification
9.5.3 AstraZeneca plc, Inc. Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 GlaxoSmithKline, Inc.
9.6.1 GlaxoSmithKline, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification
9.6.3 GlaxoSmithKline, Inc. Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Salix Pharmaceuticals, Inc.
9.7.1 Salix Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification
9.7.3 Salix Pharmaceuticals, Inc. Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Pfizer, Inc.
9.8.1 Pfizer, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Opioid-Induced Constipation (OIC) Treatment Product Profiles, Application and Specification
9.8.3 Pfizer, Inc. Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Opioid-Induced Constipation (OIC) Treatment Product Picture
Table Global Opioid-Induced Constipation (OIC) Treatment Market Sales Volume and CAGR (%) Comparison by Type
Table Opioid-Induced Constipation (OIC) Treatment Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Opioid-Induced Constipation (OIC) Treatment Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Opioid-Induced Constipation (OIC) Treatment Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Opioid-Induced Constipation (OIC) Treatment Industry Development
Table Global Opioid-Induced Constipation (OIC) Treatment Sales Volume by Player (2017-2022)
Table Global Opioid-Induced Constipation (OIC) Treatment Sales Volume Share by Player (2017-2022)
Figure Global Opioid-Induced Constipation (OIC) Treatment Sales Volume Share by Player in 2021
Table Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) by Player (2017-2022)
Table Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Player (2017-2022)
Table Opioid-Induced Constipation (OIC) Treatment Price by Player (2017-2022)
Table Opioid-Induced Constipation (OIC) Treatment Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Opioid-Induced Constipation (OIC) Treatment Sales Volume, Region Wise (2017-2022)
Table Global Opioid-Induced Constipation (OIC) Treatment Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Opioid-Induced Constipation (OIC) Treatment Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Opioid-Induced Constipation (OIC) Treatment Sales Volume Market Share, Region Wise in 2021
Table Global Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD), Region Wise (2017-2022)
Table Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share, Region Wise (2017-2022)
Figure Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share, Region Wise (2017-2022)
Figure Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share, Region Wise in 2021
Table Global Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Opioid-Induced Constipation (OIC) Treatment Sales Volume by Type (2017-2022)
Table Global Opioid-Induced Constipation (OIC) Treatment Sales Volume Market Share by Type (2017-2022)
Figure Global Opioid-Induced Constipation (OIC) Treatment Sales Volume Market Share by Type in 2021
Table Global Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) by Type (2017-2022)
Table Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Type (2017-2022)
Figure Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Type in 2021
Table Opioid-Induced Constipation (OIC) Treatment Price by Type (2017-2022)
Figure Global Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate of Peripherally-Restricted ?-opioid Receptor Antagonist (PAMORA) (2017-2022)
Figure Global Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) and Growth Rate of Peripherally-Restricted ?-opioid Receptor Antagonist (PAMORA) (2017-2022)
Figure Global Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate of Non-selective opioid antagonist (2017-2022)
Figure Global Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) and Growth Rate of Non-selective opioid antagonist (2017-2022)
Figure Global Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate of ?-Opioid antagonist (2017-2022)
Figure Global Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) and Growth Rate of ?-Opioid antagonist (2017-2022)
Figure Global Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate of Locally Acting Chloride Channel Activator (LACCA) (2017-2022)
Figure Global Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) and Growth Rate of Locally Acting Chloride Channel Activator (LACCA) (2017-2022)
Table Global Opioid-Induced Constipation (OIC) Treatment Consumption by Application (2017-2022)
Table Global Opioid-Induced Constipation (OIC) Treatment Consumption Market Share by Application (2017-2022)
Table Global Opioid-Induced Constipation (OIC) Treatment Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Opioid-Induced Constipation (OIC) Treatment Consumption Revenue Market Share by Application (2017-2022)
Table Global Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate of Drug store (2017-2022)
Table Global Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate of Independent Pharmacies (2017-2022)
Table Global Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate of Hospital Pharmacies (2017-2022)
Figure Global Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Opioid-Induced Constipation (OIC) Treatment Price and Trend Forecast (2022-2027)
Figure USA Opioid-Induced Constipation (OIC) Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Opioid-Induced Constipation (OIC) Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Opioid-Induced Constipation (OIC) Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Opioid-Induced Constipation (OIC) Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Opioid-Induced Constipation (OIC) Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Opioid-Induced Constipation (OIC) Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Opioid-Induced Constipation (OIC) Treatment Market Sales Volume Forecast, by Type
Table Global Opioid-Induced Constipation (OIC) Treatment Sales Volume Market Share Forecast, by Type
Table Global Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) Forecast, by Type
Table Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share Forecast, by Type
Table Global Opioid-Induced Constipation (OIC) Treatment Price Forecast, by Type
Figure Global Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) and Growth Rate of Peripherally-Restricted ?-opioid Receptor Antagonist (PAMORA) (2022-2027)
Figure Global Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) and Growth Rate of Peripherally-Restricted ?-opioid Receptor Antagonist (PAMORA) (2022-2027)
Figure Global Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) and Growth Rate of Non-selective opioid antagonist (2022-2027)
Figure Global Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) and Growth Rate of Non-selective opioid antagonist (2022-2027)
Figure Global Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) and Growth Rate of ?-Opioid antagonist (2022-2027)
Figure Global Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) and Growth Rate of ?-Opioid antagonist (2022-2027)
Figure Global Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) and Growth Rate of Locally Acting Chloride Channel Activator (LACCA) (2022-2027)
Figure Global Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) and Growth Rate of Locally Acting Chloride Channel Activator (LACCA) (2022-2027)
Table Global Opioid-Induced Constipation (OIC) Treatment Market Consumption Forecast, by Application
Table Global Opioid-Induced Constipation (OIC) Treatment Consumption Market Share Forecast, by Application
Table Global Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) Forecast, by Application
Table Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share Forecast, by Application
Figure Global Opioid-Induced Constipation (OIC) Treatment Consumption Value (Million USD) and Growth Rate of Drug store (2022-2027)
Figure Global Opioid-Induced Constipation (OIC) Treatment Consumption Value (Million USD) and Growth Rate of Independent Pharmacies (2022-2027)
Figure Global Opioid-Induced Constipation (OIC) Treatment Consumption Value (Million USD) and Growth Rate of Hospital Pharmacies (2022-2027)
Figure Opioid-Induced Constipation (OIC) Treatment Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Takeda Pharmaceutical Company Limited Profile
Table Takeda Pharmaceutical Company Limited Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Takeda Pharmaceutical Company Limited Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate
Figure Takeda Pharmaceutical Company Limited Revenue (Million USD) Market Share 2017-2022
Table Cubist Pharmaceuticals Profile
Table Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate
Figure Cubist Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table AIKO Biotechnology Profile
Table AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate
Figure AIKO Biotechnology Revenue (Million USD) Market Share 2017-2022
Table S.L.A. Pharma AG Profile
Table S.L.A. Pharma AG Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure S.L.A. Pharma AG Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate
Figure S.L.A. Pharma AG Revenue (Million USD) Market Share 2017-2022
Table AstraZeneca plc, Inc. Profile
Table AstraZeneca plc, Inc. Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AstraZeneca plc, Inc. Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate
Figure AstraZeneca plc, Inc. Revenue (Million USD) Market Share 2017-2022
Table GlaxoSmithKline, Inc. Profile
Table GlaxoSmithKline, Inc. Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GlaxoSmithKline, Inc. Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate
Figure GlaxoSmithKline, Inc. Revenue (Million USD) Market Share 2017-2022
Table Salix Pharmaceuticals, Inc. Profile
Table Salix Pharmaceuticals, Inc. Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Salix Pharmaceuticals, Inc. Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate
Figure Salix Pharmaceuticals, Inc. Revenue (Million USD) Market Share 2017-2022
Table Pfizer, Inc. Profile
Table Pfizer, Inc. Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer, Inc. Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate
Figure Pfizer, Inc. Revenue (Million USD) Market Share 2017-2022
Figure Opioid-Induced Constipation (OIC) Treatment Product Picture
Table Global Opioid-Induced Constipation (OIC) Treatment Market Sales Volume and CAGR (%) Comparison by Type
Table Opioid-Induced Constipation (OIC) Treatment Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Opioid-Induced Constipation (OIC) Treatment Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Opioid-Induced Constipation (OIC) Treatment Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Opioid-Induced Constipation (OIC) Treatment Industry Development
Table Global Opioid-Induced Constipation (OIC) Treatment Sales Volume by Player (2017-2022)
Table Global Opioid-Induced Constipation (OIC) Treatment Sales Volume Share by Player (2017-2022)
Figure Global Opioid-Induced Constipation (OIC) Treatment Sales Volume Share by Player in 2021
Table Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) by Player (2017-2022)
Table Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Player (2017-2022)
Table Opioid-Induced Constipation (OIC) Treatment Price by Player (2017-2022)
Table Opioid-Induced Constipation (OIC) Treatment Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Opioid-Induced Constipation (OIC) Treatment Sales Volume, Region Wise (2017-2022)
Table Global Opioid-Induced Constipation (OIC) Treatment Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Opioid-Induced Constipation (OIC) Treatment Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Opioid-Induced Constipation (OIC) Treatment Sales Volume Market Share, Region Wise in 2021
Table Global Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD), Region Wise (2017-2022)
Table Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share, Region Wise (2017-2022)
Figure Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share, Region Wise (2017-2022)
Figure Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share, Region Wise in 2021
Table Global Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Opioid-Induced Constipation (OIC) Treatment Sales Volume by Type (2017-2022)
Table Global Opioid-Induced Constipation (OIC) Treatment Sales Volume Market Share by Type (2017-2022)
Figure Global Opioid-Induced Constipation (OIC) Treatment Sales Volume Market Share by Type in 2021
Table Global Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) by Type (2017-2022)
Table Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Type (2017-2022)
Figure Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Type in 2021
Table Opioid-Induced Constipation (OIC) Treatment Price by Type (2017-2022)
Figure Global Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate of Peripherally-Restricted ?-opioid Receptor Antagonist (PAMORA) (2017-2022)
Figure Global Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) and Growth Rate of Peripherally-Restricted ?-opioid Receptor Antagonist (PAMORA) (2017-2022)
Figure Global Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate of Non-selective opioid antagonist (2017-2022)
Figure Global Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) and Growth Rate of Non-selective opioid antagonist (2017-2022)
Figure Global Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate of ?-Opioid antagonist (2017-2022)
Figure Global Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) and Growth Rate of ?-Opioid antagonist (2017-2022)
Figure Global Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate of Locally Acting Chloride Channel Activator (LACCA) (2017-2022)
Figure Global Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) and Growth Rate of Locally Acting Chloride Channel Activator (LACCA) (2017-2022)
Table Global Opioid-Induced Constipation (OIC) Treatment Consumption by Application (2017-2022)
Table Global Opioid-Induced Constipation (OIC) Treatment Consumption Market Share by Application (2017-2022)
Table Global Opioid-Induced Constipation (OIC) Treatment Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Opioid-Induced Constipation (OIC) Treatment Consumption Revenue Market Share by Application (2017-2022)
Table Global Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate of Drug store (2017-2022)
Table Global Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate of Independent Pharmacies (2017-2022)
Table Global Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate of Hospital Pharmacies (2017-2022)
Figure Global Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Opioid-Induced Constipation (OIC) Treatment Price and Trend Forecast (2022-2027)
Figure USA Opioid-Induced Constipation (OIC) Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Opioid-Induced Constipation (OIC) Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Opioid-Induced Constipation (OIC) Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Opioid-Induced Constipation (OIC) Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Opioid-Induced Constipation (OIC) Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Opioid-Induced Constipation (OIC) Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Opioid-Induced Constipation (OIC) Treatment Market Sales Volume Forecast, by Type
Table Global Opioid-Induced Constipation (OIC) Treatment Sales Volume Market Share Forecast, by Type
Table Global Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) Forecast, by Type
Table Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share Forecast, by Type
Table Global Opioid-Induced Constipation (OIC) Treatment Price Forecast, by Type
Figure Global Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) and Growth Rate of Peripherally-Restricted ?-opioid Receptor Antagonist (PAMORA) (2022-2027)
Figure Global Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) and Growth Rate of Peripherally-Restricted ?-opioid Receptor Antagonist (PAMORA) (2022-2027)
Figure Global Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) and Growth Rate of Non-selective opioid antagonist (2022-2027)
Figure Global Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) and Growth Rate of Non-selective opioid antagonist (2022-2027)
Figure Global Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) and Growth Rate of ?-Opioid antagonist (2022-2027)
Figure Global Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) and Growth Rate of ?-Opioid antagonist (2022-2027)
Figure Global Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) and Growth Rate of Locally Acting Chloride Channel Activator (LACCA) (2022-2027)
Figure Global Opioid-Induced Constipation (OIC) Treatment Revenue (Million USD) and Growth Rate of Locally Acting Chloride Channel Activator (LACCA) (2022-2027)
Table Global Opioid-Induced Constipation (OIC) Treatment Market Consumption Forecast, by Application
Table Global Opioid-Induced Constipation (OIC) Treatment Consumption Market Share Forecast, by Application
Table Global Opioid-Induced Constipation (OIC) Treatment Market Revenue (Million USD) Forecast, by Application
Table Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share Forecast, by Application
Figure Global Opioid-Induced Constipation (OIC) Treatment Consumption Value (Million USD) and Growth Rate of Drug store (2022-2027)
Figure Global Opioid-Induced Constipation (OIC) Treatment Consumption Value (Million USD) and Growth Rate of Independent Pharmacies (2022-2027)
Figure Global Opioid-Induced Constipation (OIC) Treatment Consumption Value (Million USD) and Growth Rate of Hospital Pharmacies (2022-2027)
Figure Opioid-Induced Constipation (OIC) Treatment Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Takeda Pharmaceutical Company Limited Profile
Table Takeda Pharmaceutical Company Limited Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Takeda Pharmaceutical Company Limited Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate
Figure Takeda Pharmaceutical Company Limited Revenue (Million USD) Market Share 2017-2022
Table Cubist Pharmaceuticals Profile
Table Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate
Figure Cubist Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table AIKO Biotechnology Profile
Table AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate
Figure AIKO Biotechnology Revenue (Million USD) Market Share 2017-2022
Table S.L.A. Pharma AG Profile
Table S.L.A. Pharma AG Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure S.L.A. Pharma AG Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate
Figure S.L.A. Pharma AG Revenue (Million USD) Market Share 2017-2022
Table AstraZeneca plc, Inc. Profile
Table AstraZeneca plc, Inc. Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AstraZeneca plc, Inc. Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate
Figure AstraZeneca plc, Inc. Revenue (Million USD) Market Share 2017-2022
Table GlaxoSmithKline, Inc. Profile
Table GlaxoSmithKline, Inc. Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GlaxoSmithKline, Inc. Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate
Figure GlaxoSmithKline, Inc. Revenue (Million USD) Market Share 2017-2022
Table Salix Pharmaceuticals, Inc. Profile
Table Salix Pharmaceuticals, Inc. Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Salix Pharmaceuticals, Inc. Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate
Figure Salix Pharmaceuticals, Inc. Revenue (Million USD) Market Share 2017-2022
Table Pfizer, Inc. Profile
Table Pfizer, Inc. Opioid-Induced Constipation (OIC) Treatment Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer, Inc. Opioid-Induced Constipation (OIC) Treatment Sales Volume and Growth Rate
Figure Pfizer, Inc. Revenue (Million USD) Market Share 2017-2022
